About FDA
Percent of actions listed in OSEL research plans completed on time during the month (1)
Dictionary: OSEL conducts laboratory and field research in the areas of physical, life, and engineering sciences as it relates to the effects of medical devices on human health. This measure intends to monitor the progression of OSEL’s research projects by establishing milestone goals and tracking timely completion of these milestones.
Fiscal Year - 2011
| Time | Target | Percent |
|---|---|---|
| Oct 2010 | 75 | 80 |
| Nov 2010 | 75 | 74 |
| Dec 2010 | 75 | 77 |
| Jan 2011 | 75 | 86 |
| Feb 2011 | 75 | 83 |
| Mar 2011 | 75 | 84 |
| Apr 2011 | 75 | 87 |
| May 2011 | 75 | 84 |
| Jun 2011 | 75 | 90 |
| Jul 2011 | 75 | 89 |
| Aug 2011 | 75 | 89 |
| Sep 2011 | 75 | 86 |
FY 2011 Overall: 84%
Footnotes
- (1) Measure was implemented April 1, 2010.
Number of actions in OSEL research plans completed on time during the month
Fiscal Year - 2011
| Time | Target | Number |
|---|---|---|
| Oct 2010 | N/A | 32 |
| Nov 2010 | N/A | 26 |
| Dec 2010 | N/A | 40 |
| Jan 2011 | N/A | 30 |
| Feb 2011 | N/A | 25 |
| Mar 2011 | N/A | 38 |
| Apr 2011 | N/A | 26 |
| May 2011 | N/A | 27 |
| Jun 2011 | N/A | 38 |
| Jul 2011 | N/A | 25 |
| Aug 2011 | N/A | 31 |
| Sep 2011 | N/A | 30 |
FY 2011 Total: 368
Number of actions in OSEL research plans completed during the month
Fiscal Year - 2011
| Time | Target | Number |
|---|---|---|
| Oct 2010 | N/A | 40 |
| Nov 2010 | N/A | 35 |
| Dec 2010 | N/A | 52 |
| Jan 2011 | N/A | 35 |
| Feb 2011 | N/A | 30 |
| Mar 2011 | N/A | 45 |
| Apr 2011 | N/A | 30 |
| May 2011 | N/A | 32 |
| Jun 2011 | N/A | 42 |
| Jul 2011 | N/A | 28 |
| Aug 2011 | N/A | 35 |
| Sep 2011 | N/A | 35 |
FY 2011 Total: 439
Total number of OSEL research plans in progress
Fiscal Year - 2011
| Time | Target | Number |
|---|---|---|
| Oct 2010 | N/A | 57 |
| Nov 2010 | N/A | 57 |
| Dec 2010 | N/A | 57 |
| Jan 2011 | N/A | 57 |
| Feb 2011 | N/A | 57 |
| Mar 2011 | N/A | 57 |
| Apr 2011 | N/A | 57 |
| May 2011 | N/A | 57 |
| Jun 2011 | N/A | 57 |
| Jul 2011 | N/A | 57 |
| Aug 2011 | N/A | 57 |
| Sep 2011 | N/A | 57 |
Glossary
Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.
